Biological pathways involved in the development of inflammatory bowel disease

被引:3
|
作者
Zemljic, Mateja [1 ]
Pejkovic, Bozena [1 ]
Krajnc, Ivan [2 ]
Lipovsek, Saska [3 ]
机构
[1] Univ Maribor, Fac Med, Inst Anat Histol & Embryol, SLO-2000 Maribor, Slovenia
[2] Univ Maribor, Fac Med, Dept Internal Med, SLO-2000 Maribor, Slovenia
[3] Univ Maribor, Fac Med, Dept Cell Biol, SLO-2000 Maribor, Slovenia
关键词
Apoptosis; Autophagy; Necrosis; Inflammatory bowel disease; Homeostasis; TUMOR-NECROSIS-FACTOR; INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; CROHNS-DISEASE; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; AUTOPHAGY GENES; CANCER-THERAPY; FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS;
D O I
10.1007/s00508-014-0592-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apoptosis, autophagy and necrosis are three distinct functional types of the mammalian cell death network. All of them are characterized by a number of cell's morphological changes. The inappropriate induction of cell death is involved in the pathogenesis of a number of diseases. Pathogenesis of inflammatory bowel diseases (ulcerative colitis, Crohn's disease) includes an abnormal immunological response to disturbed intestinal microflora. One of the most important reason in pathogenesis of chronic inflammatory disease and subsequent multiple organ pathology is a barrier function of the gut, regulating cellular viability. Recent findings have begun to explain the mechanisms by which intestinal epithelial cells are able to survive in such an environment and how loss of normal regulatory processes may lead to inflammatory bowel disease (IBD). This review focuses on the regulation of biological pathways in development and homeostasis in IBD. Better understanding of the physiological functions of biological pathways and their influence on inflammation, immunity, and barrier function will simplify our expertice of homeostasis in the gastrointestinal tract and in upgrading diagnosis and treatment.
引用
收藏
页码:626 / 633
页数:8
相关论文
共 50 条
  • [31] Current biological therapies for inflammatory bowel disease
    Baumgart, DC
    Dignass, AU
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (32) : 4127 - 4147
  • [32] Cytokine pathways in inflammatory bowel disease - the yin and the yang
    Elson, C. O.
    Cong, Y.
    Maynard, C.
    Weaver, C.
    FUTURE PERSPECTIVES IN GASTROENTEROLOGY, 2008, 161 : 20 - 25
  • [33] AMINO ACID SENSING PATHWAYS IN INFLAMMATORY BOWEL DISEASE
    Solanki, Sumeet
    Lee, Jun-Hee
    Shah, Yatrik
    GASTROENTEROLOGY, 2022, 162 (03) : S23 - S24
  • [34] AMINO ACID SENSING PATHWAYS IN INFLAMMATORY BOWEL DISEASE
    Solanki, Sumeet
    Lee, Jun-Hee
    Shah, Yatrik
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S23 - S24
  • [35] Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I466 - I466
  • [36] Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I466 - I466
  • [37] Biological markers of disease activity in inflammatory bowel diseases
    Szymanska, Edyta
    Szymanska, Sylwia
    Dadalski, Maciej
    Kierkus, Jaroslaw
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2023, 18 (02): : 141 - 147
  • [38] Relationship between the Biological Clock and Inflammatory Bowel Disease
    Giebfried, Jonathan
    Lorentz, Axel
    CLOCKS & SLEEP, 2023, 5 (02): : 260 - 275
  • [39] The pathophysiologic rationale for biological therapies in inflammatory bowel disease
    Gordon, JN
    Di Sabatino, A
    MacDonald, TT
    CURRENT OPINION IN GASTROENTEROLOGY, 2005, 21 (04) : 431 - 437
  • [40] Molecular biological studies of the pathogenesis in inflammatory bowel disease
    Hibi, T
    INTERNAL MEDICINE, 2003, 42 (03) : 285 - 287